Fundraising FoxOmios Biologics
2 known investors
Find your way into Omios Biologics
Sign up to see every warm intro you have to Omios Biologics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Omios Biologics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Omios Biologics runs a computational drug discovery platform that analyzes viral-host interactions across more than 270 human viruses to identify disease targets and engineer precision therapeutics. Its lead assets are biomarker-driven engineered oncolytic viruses for specific cancer subtypes, with expansion into immune, inflammatory, metabolic, and neurodegenerative diseases.
Investors · 2
Frequently asked questions
- What does Omios Biologics do?
- Omios Biologics runs a computational drug discovery platform that analyzes viral-host interactions across more than 270 human viruses to identify disease targets and engineer precision therapeutics. Its lead assets are biomarker-driven engineered oncolytic viruses for specific cancer subtypes, with expansion into immune, inflammatory, metabolic, and neurodegenerative diseases.
- Who are Omios Biologics's investors?
- Omios Biologics's investors include FuturePlay, NYU Innovation Venture Fund.